IT vs REGN · P/E 16, rev $6.27B vs P/E 14, rev $14.34B
Gartner Inc (IT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IT currently screens at market cap $11.03B and trailing P/E 16.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IT and REGN stock pages for the full models.
Not investment advice.